Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Screpanti

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Plos One|November 16, 2012
Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cellsVeronica Veschi, Marialaura Petroni, Beatrice Cardinali, et al.
Blood|December 22, 2005
Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesisClaudio Talora, Samantha Cialfi, Christian Oliviero, et al.
Pharmaceutics|August 1, 2020
Current Trends in ATRA Delivery for Cancer TherapyMaria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, et al.
Cancer Cell|March 3, 2009
Proapoptotic function of the retinoblastoma tumor suppressor proteinAlessandra Ianari, Tiziana Natale, Eliezer Calo, et al.
Experimental Cell Research|April 9, 2005
Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathwaysClaudio Talora, Samantha Cialfi, Oreste Segatto, et al.
Cancers|October 23, 2021
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future PerspectivesNadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari, et al.
British Journal of Haematology|July 17, 2009
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutationMauro Di Ianni, Stefano Baldoni, Emanuela Rosati, et al.
Cancer Research|September 17, 2005
High mobility group A1 is a molecular target for MYCN in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Molecular Carcinogenesis|March 6, 2012
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1Isabella Massimi, Francesca Guerrieri, Marialaura Petroni, et al.
International Immunology|October 29, 2015
CD3ε recruits Numb to promote TCR degradationNadia Martin-Blanco, Daniel Jiménez Teja, Gabriel Bretones, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Plos One|November 16, 2012
Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cellsVeronica Veschi, Marialaura Petroni, Beatrice Cardinali, et al.
Blood|December 22, 2005
Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesisClaudio Talora, Samantha Cialfi, Christian Oliviero, et al.
Pharmaceutics|August 1, 2020
Current Trends in ATRA Delivery for Cancer TherapyMaria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, et al.
Cancer Cell|March 3, 2009
Proapoptotic function of the retinoblastoma tumor suppressor proteinAlessandra Ianari, Tiziana Natale, Eliezer Calo, et al.
Experimental Cell Research|April 9, 2005
Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathwaysClaudio Talora, Samantha Cialfi, Oreste Segatto, et al.
Cancers|October 23, 2021
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future PerspectivesNadezda Zhdanovskaya, Mariarosaria Firrincieli, Sara Lazzari, et al.
British Journal of Haematology|July 17, 2009
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutationMauro Di Ianni, Stefano Baldoni, Emanuela Rosati, et al.
Cancer Research|September 17, 2005
High mobility group A1 is a molecular target for MYCN in human neuroblastomaGiuseppe Giannini, Fabio Cerignoli, Massimiliano Mellone, et al.
Molecular Carcinogenesis|March 6, 2012
The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1Isabella Massimi, Francesca Guerrieri, Marialaura Petroni, et al.
International Immunology|October 29, 2015
CD3ε recruits Numb to promote TCR degradationNadia Martin-Blanco, Daniel Jiménez Teja, Gabriel Bretones, et al.
Pageof 15